Skip to Content

'
Abigail S. Caudle, MD

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2013 University of Michigan School of Public Health, Ann Arbor, MI, MS, Clinical Research Design and Statistical Analysis
2000 University of North Carolina School of Medicine, Chapel Hill, NC, MD, Medicine
1995 University of North Carolina, Chapel Hill, NC, BS, Biology and Chemistry

Postgraduate Training

2008-2009 Research Fellowship, Surgical Oncology Research, NIH T-32 Training Grant, The University of Texas MD Anderson Cancer Center, Houston, TX
2007-2010 Clinical Fellowship, Surgical Oncology Fellow, The University of Texas MD Anderson Cancer Center, Houston, TX
2005-2007 Research Fellowship, Surgical Oncology, NIH T-32 Training Grant, University of North Carolina, Chapel Hill, NC
2000-2005 Clinical Residency, General Surgery, University of North Carolina, Chapel Hill, NC

Board Certifications

5/2006 American Board of Surgery

Experience/Service

Institutional Committee Activities

Committee Member, Surgical Oncology Curriculum Task Force, 2011-present
Committee Member, OR Block Utilization Task Force, 2011-present
Committee Member, Patient Care Task Force, 2011-present
Committee Member, Surgical Oncology Education, 2010-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, Arun BK, Lucci A, Babiera GV, Wagner JL, Caudle AS, Meric-Bernstam F, Hwang RF, Bedrosian I, Hunt KK, Kuerer HM. Biology, Treatment, and Outcome in Very Young and Older Women with DCIS. Ann Surg Oncol 19(12):3777-84, 11/2012. e-Pub 5/2012. PMID: 22622473.
2. Caudle AS, Hunt KK, Tucker SL, Hoffman K, Gainer SM, Lucci A, Kuerer HM, Meric-Bernstam F, Shah R, Babiera GV, Sahin AA, Mittendorf EA. American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on surgeon practice patterns. Ann Surg Oncol 19(10):3144-51, 10/2012. e-Pub 7/2012. PMID: 22847123.
3. Gainer SM, Hunt KK, Beitsch P, Caudle AS, Mittendorf EA, Lucci A. Changing behavior in clinical practice in response to the ACOSOG Z0011 Trial: A survey of the American Society of Breast Surgeons. Ann Surg Oncol 19(10):3152-8, 10/2012. e-Pub 7/2012. PMID: 22820938.
4. Alvarado R, Yi M, Le-Petross H, Gilcrease M, Mittendorf EA, Bedrosian I, Hwang RF, Caudle AS, Babiera GV, Akins JS, Kuerer HM, Hunt KK. The role for sentinel lymph node biopsy after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. Ann Surg Oncol 19(10):3177-84, 10/2012. e-Pub 7/2012. PMID: 22772869.
5. Kuerer HM, Lari SA, Arun BK, Hu CY, Brewster A, Mittendorf EA, Albarracin CT, Babiera GV, Caudle AS, Wagner JL, Litton JK, Bedrosian I, Meric-Bernstam F, Lucci A, Hunt KK. Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass. Breast Cancer Res Treat 133(3):1131-41, 6/2012. e-Pub 3/2012. PMID: 22392043.
6. Caudle AS, Yu TK, Tucker SL, Bedrosian I, Litton JK, Gonzalez-Angulo AM, Hoffman K, Meric-Bernstam F, Hunt KK, Buchholz TA, Mittendorf EA. Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy. Breast Cancer Res 14(3):R83, 2012. e-Pub 5/2012. PMCID: PMC3446346.
7. Caudle AS, Hunt KK, Kuerer HM, Meric-Bernstam F, Lucci A, Bedrosian I, Babiera GV, Hwang RF, Ross MI, Feig BW, Hoffman K, Litton JK, Sahin AA, Yang W, Hortobagyi GN, Buchholz TA, Mittendorf EA. Multidisciplinary considerations in the implementation of the findings from the american college of surgeons oncology group (ACOSOG) Z0011 Study: A Practice-Changing Trial. Ann Surg Oncol 18(9):2407-12, 9/2011. e-Pub 2/2011. PMID: 21327455.
8. Caudle AS, Gonzalez-Angulo AM, Hunt KK, Pusztai L, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancer. Ann Surg Oncol 18(4):932-8, 4/2011. e-Pub 11/2010. PMID: 21061075.
9. Poindexter NJ, Williams RR, Powis G, Jen E, Caudle AS, Chada S, Grimm EA. IL-24 is expressed during wound repair and inhibits TGFalpha-induced migration and proliferation of keratinocytes. Exp Dermatol 19(8):714-22, 8/2010. PMID: 20545760.
10. Caudle AS, Gonzalez-Angulo AM, Hunt KK, Liu P, Pusztai L, Symmans WF, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer. J Clin Oncol 28(11):1821-8, 4/2010. e-Pub 3/2010. PMCID: PMC2860366.
11. Kiser M, Caudle AS, von Allmen D. Multicentric paragangliomas associated with Carney triad. Am Surg 76(2):216-8, 2/2010. PMID: 20336905.
12. Beasley GM, Caudle AS, Petersen RP, McMahon NS, Padussis J, Mosca PJ, Zager JS, Hochwald SN, Grobmyer SR, Delman KA, Andtbacka RH, Noyes RD, Kane JM, Seigler H, Pruitt SK, Ross MI, Tyler DS. A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US. J Am Coll Surg 208(5):706-15; discussion 715-7, 5/2009. e-Pub 3/2009. PMID: 19476821.
13. Caudle AS, Kim HJ, Tepper JE, O'Neil BH, Lange LA, Goldberg RM, Bernard SA, Calvo BF, Meyers MO. Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer. Ann Surg Oncol 15(7):1931-6, 7/2008. e-Pub 4/2008. PMID: 18418656.
14. Caudle AS, Tepper JE, Calvo BF, Meyers MO, Goyal LK, Cance WG, Kim HJ. Complications associated with neoadjuvant radiotherapy in the multidisciplinary treatment of retroperitoneal sarcomas. Ann Surg Oncol 14(2):577-82, 2/2007. e-Pub 11/2006. PMID: 17119868.
15. Caudle AS, Brier SE, Calvo BF, Kim HJ, Meyers MO, Ollila DW. Experienced radio-guided surgery teams can successfully perform minimally invasive radio-guided parathyroidectomy without intraoperative parathyroid hormone assays. Am Surg 72(9):785-9; discussion 790, 9/2006. PMID: 16986387.
16. Ollila DW, Caudle AS, Cance WG, Kim HJ, Cusack JC, Swasey JE, Calvo BF. Successful minimally invasive parathyroidectomy for primary hyperparathyroidism without using intraoperative parathyroid hormone assays. Am J Surg 191(1):52-6, 1/2006. PMID: 16399106.

Invited Articles

1. Caudle AS,HM Kuerer. Large national cooperative group trial examines survival endpoint associated with breast cancer occult metastases. J Watch Oncol and Hematol. In Press.
2. Caudle AS. Is there a role for sentinel lymph node dissection in patients with ductal carcinoma in situ? Breast Diseases: A Year Book Quarterly 23(1), 4/2012.
3. Caudle AS. Does blue dye contribute to success of sentinel node mapping for breast cancer. Breast Diseases:A Year Book Quarterly 22(3), 10/2011.
4. Caudle AS, Hunt KK. The neoadjuvant approach in breast cancer treatment: it is not just about chemotherapy anymore. Curr Opin Obstet Gynecol 23(1):31-6, 2/2011. PMID: 21124221.
5. Caudle AS, Ross MI. Metastasectomy for Stage IV Melanoma: For Whom and How Much? Surg Oncol Clin N Am 20(1):133-44, 1/2011. PMID: 21111963.
6. Ollila DW, Caudle AS. Surgical management of distant metastases. Surg Oncol Clin N Am 15(2):385-98, 4/2006. PMID: 16632222.

Abstracts

1. Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, Arun BK, Lucci A, Babiera GV, Wagner JL, Caudle AS, Meric-Bernstam F, Hwang RF, Bedrosian I, Hunt KK, Kuerer HM. Biology, Treatment, and Outcome in Very Young and Older Women with DCIS. Ann Surg Oncol 17 (Suppl 1)(s58). e-Pub 5/2012. PMID: 22622473.
2. Caudle AS, Hunt KK, Tucker SL, Hoffman K, Gainer SM, Lucci A, Kuerer HM, Meric-Bernstam F, Shah R, Babiera GV, Sahin AA, Mittendorf EA. American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on surgeon practice patterns. American Society of Breast Surgeons Official Proceedings (#0055), 2012.
3. Gainer SM, Hunt KK, Beitsch P, Caudle AS, Mittendorf EA, Lucci A. Changing behavior in clinical practice in response to the ACOSOG Z0011 Trial: A survey of the American Society of Breast Surgeons. Ann Surg Oncol (#0072), 2012. PMID: 22820938.
4. Dallas NA, Yi M, Hunt KK, Shah R, Kuerer HM, Litton JK, Wu Y, Caudle AS, Meric-Bernstam F, Sahin AA, Mittendorf EA. Evaluation of the stage IB designation of the 7th Edition of the AJCC Staging System: Receptor status and nuclear grade are better survival discriminants than presence of micrometastases. J Clin Oncol 30(Suppl) (#1130), 2012.
5. Caudle AS, Min Y, Mittendorf EA, Babiera GV, Hwang RF, Meric-Bernstam F, Sahin. The identification of internal mammary sentinel lymph node metastasis impacts therapy in breast cancer. American Society of Breast Surgeons Official (#168), 2012.
6. Alvarado R, Yi M, Le-Petross H, Gilcrease M, Mittendorf EA, Bedrosian I, Hwang RF, Caudle AS, Babiera GV, Akins JS, Kuerer HM, Hunt KK. The role for sentinel lymph node biopsy after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. American Society of Breast Surgeons Official Proceedings (#183), 2012. PMID: 22772869.
7. Smith MB, Caudle AS, Caskey LS, Meyers MO, Moore DT, Calvo BF. Epiregulin mRNA expression in colorectal hepatic metastases is associated with survival post partial hepatectomy. Ann Surg Oncol 17(Suppl 1):S24 (#58), 2010.
8. Caudle AS, Ross MI, Prieto VG, Warneke CL, Lee JE, Johnson MM, Gardner JL, Royal RE, Cormier JN, Lucci A, Gershenwald JE. Mitotic rate predicts sentinel node involvement in melanoma: Impact of the 7th edition AJCC melanoma staging system. Ann Surg Oncol 17(Suppl 1):S8 (#7), 2010.
9. Yeh JJ, Caudle AS, McPhail L, Sigel CS, Caskey L, Routh ED, Kim HJ, Meyers MO, Calvo BF. A molecular signature of clinical risk in patients with colorectal liver metastasis. Ann Surg Oncol 16(S1):S17 (#52), Feb, 2009.
10. Caudle AS, Poindexter N, Grimm EA. Differential regulation of EGFR by IL-24 in human melanoma cells and melanocytes. Proc 100th Ann Mtg of AACR (#4462), 2009.
11. Caudle AS, Gonzalez-Angulo AM, Hunt KK, Pusztai L, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Impact of Progression during Neoadjuvant Chemotherapy on Operative Management of Breast Cancer. Cancer Research 69(24):567s (#1090), Dec 15, 2009.
12. Sommer CA, Calvo BF, Caudle AS, Yeh JJ, Frank JS, Ollila DW. Multiple strategies to ensure a successful minimally invasive parathyroidectomy. Ann Surg Oncol 16(Suppl 2):51 (#60), 2009.
13. Caudle AS, Gonzalez-Angulo A, Hunt KK, Ping L, Pusztai L, Symman F, Kuerer H, Mittendorf EA, Hortobagyi G, Meric-Bernstam F. Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer. J Clin Oncol 27:15s (#603), 2009.
14. Caudle AS, Willborn K, Abdalla EK, Evans DB, Vauthey JN, Ellis LM, Yao JC. Feasibility of synchronous resection of primary and metastatic. Ann Surg Oncol 15(S2):51 (#60), Feb, 2008.
15. Caudle AS, Caskey LS, Earp HS, Calvo BF. Increased amphiregulin and epiregulin expression in colorectal tumors may explain clinical response to EGFR-targeted antibody therapy. Ann Surg Oncol 14(Suppl 2), Feb, 2007.
16. Caudle AS, Rubinas TC, Caskey LS, Earp HS, Calvo BF. Measuring the epidermal growth factor receptor and its ligands in paraffin-embedded archived patient samples. ASCO GI Symposium;Orlando, FL (#439), 2007.
17. Caudle AS, Caskey LS, Earp HS, Calvo BF. Colorectal adenocarcinomas have increased EGFR ligand expression. J Am Coll Surg 203(3):S87, Sep, 2006.
18. Caudle AS, Calvo BF, Kim HJ, Bernard S, Tepper JE, O’Neil BH, Meyers MO. Diabetes decreases response to neoadjuvant therapy in rectal cancer. Ann Surg Oncol 13(S1) (#P131), Feb, 2006.
19. Caudle AS, Calvo BF, Meyers MO, Cance WG, Goyal LK, Tepper JE, Kim HJ. Preoperative radiotherapy in the multidisciplinary treatment of retroperitoneal sarcomas. Ann Surg Oncol 12(Suppl), Feb, 2005.
20. Ollila DW, Caudle AS, Cance WG, Kim HJ, Cusack JC, Swasey JE, Calvo BF. Successful minimally invasive parathyroidectomy without intra-operative parathyroid hormone assay. Ann Surg Oncol 11(Suppl 2):S119 (#P122), Feb, 2004.

Book Chapters

1. Caudle AS, Delman KA, Cormier JN. Sarcoma: Soft Tissue Sarcoma, Bone Sarcoma. In: The M.D. Anderson Surgical Oncology Handbook,, 5th. Ed(s) Feig BW, Cormier JN, Ching CD. Lippincott Williams, & Wilkins: Philadelphia, PA, 2012.
2. Caudle AS, Babiera GV. Surgical Management of Disseminated Breast Cancer. In: Advanced Therapy of Breast Disease. 3rd. People’s Publishing House: Shelton, CT, 2012.
3. Caudle AS, Mittendorf EA, Kuerer HM. Lymphatic Mapping and Sentinel Lymphatic Mapping and Sentinel Lymph Node Biopsy. In: Elective General Surgery: An Evidence-Based Approach. Ed(s) Cohn SM,Brower ST. People's Medical Publishing House, 2011.
4. Caudle AS, Babiera GV. Management of Recurrent and Disseminated Breast Cancer. In: Cameron’s Current Surgical Therapy. 10th. Ed(s) Cameron JL, Cameron AM,, 952-956, 2011.
5. Caudle AS, Ollila DW. Surgical Resection of Distant Metastases: Rationale, Indications, and Results. In: Advanced Therapy in Surgical Oncology. Ed(s) Pollock RE, Curley SA, Ross MI, Perrier ND. BC Decker Hamilton: Ontario, 2008.
6. Caudle AS, Kim HJ, Tepper JE. Evidence-based Practice: The Role of Adjuvant Radiotherapy in the Treatment of Gastric Adenocarcinoma. In: Gastrointestinal Oncology: Evidence and Analysis. Ed(s) McCulloch P, Kerr D, Ajani J. Marcel Dekker: New York, 2005.
7. Caudle AS, Haas E, Walkup M, Kim HJ. Surgery Section. In: USMLE Review, Step 3, 4th. Appleton & Lange: New York, 2005.

Letters to the Editor

1. Caudle AS, Gonzalez-Angulo AM, Meric-Bernstam F. Response to Letter to the Editor: Strategy for non-responder breast cancer patients to neoadjuvant treatment. Ann Surg Oncol 18 Suppl 3:288-9, 12/2011. e-Pub 8/2011. PMID: 21826559.
2. Caudle AS, Hunt KK, Mittendorf EA. Response to the Letter to the Editor: Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A practice-changing trial. Ann Surg Oncol 18 Suppl 3:283, 12/2011. e-Pub 7/2011. PMID: 21725683.

Last updated: 5/7/2014